New Clinical Trial Takes Personalized Approach for Rare Type of ALS in Appalachia

New Clinical Trial Takes Personalized Approach for Rare Type of ALS in Appalachia

ALS, or amyotrophic lateral sclerosis, is a neurodegenerative disease of some fame in the United States. Many Americans know the illness, which currently has no cure, as Lou Gehrig’s disease, after the beloved baseball player whose career and life were cut short by the condition in the 1930s and 40s.

CCTS Conference on Opioids Draws Nearly 1,000 Participants

CCTS Conference on Opioids Draws Nearly 1,000 Participants

The 13th Annual Spring Conference of the University of Kentucky Center for Clinical and Translational Science (CCTS) was held April 13 at the Lexington Convention Center. While the CCTS supports research across the spectrum of diseases, this year’s conference focused on using translational science to address the opioid epidemic.

Annual Report Spotlights UK Research Impact on Kentucky

Annual Report Spotlights UK Research Impact on Kentucky

How is research at the University of Kentucky transforming tomorrow? The UK Research 2017 Annual Report shares the economic impact of UK research, strategic plan progress, national rankings and innovative federally funded research projects in substance abuse, cancer, diabetes and obesity, cardiovascular diseases, neuroscience and aging, and energy.